DULUTH, Ga., Oct. 8, 2020 /PRNewswire/ — Boehringer Ingelheim Animal Health launched an innovative, first-of-its-kind vaccine in the United States today to protect poultry from three diseases.
VAXXITEK® HVT+IBD+ILT is the first vaccine to offer protection in one shot from Infectious Laryngotracheitis, Marek’s Disease and Infectious Bursal Disease (classic and variant types).
“This new trivalent vaccine provides a strong immune foundation, optimizes protection for flocks and offers reliable protection,” said Matt Nelson, who leads Boehringer Ingelheim Animal Health’s U.S. poultry business.
The three-in-one vaccine is the latest addition in the VAXXITEK® family of vaccines for poultry. It uses the same bioengineering platform as VAXXITEK® HVT+IBD, which has protected more than 100 billion birds from Marek’s Disease and Infectious Bursal Disease in more than 75 countries since its introduction in 2006.
Infectious Laryngotracheitis (ILT) is an acute viral respiratory disease in poultry caused by Gallid herpesvirus type